The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index.
Translating Research Into Practice: The Schizophrenia Patient Outcomes Research Team (PORT) Treatment Recommendations
Abstract
Beginning in 1992, the Agency for Health Care Policy and Research and the National Institute of Mental Health funded the Schizophrenia Patient Outcomes Research Team (PORT) to develop and disseminate recommendations for the treatment of schizophrenia based on existing scientific evidence. These Treatment Recommendations, presented here in final form for the first time, are based on exhaustive reviews of the treatment outcomes literature (previously published in Schizophrenia Bulletin, Vol. 21, No. 4, 1995) and focus on those treatments for which there is substantial evidence of efficacy. The recommendations address antipsychotic agents, adjunctive pharmacotherapies, electroconvulsive therapy, psychological interventions, family interventions, vocational rehabilitation, and assertive community treatment/intensive case management. Support for each recommendation is referenced to the previous PORT literature reviews, and the recommendations are rated according to the level of supporting evidence. The PORT Treatment Recommendations provide a basis for moving toward "evidence-based" practice for schizophrenia and identify both the strengths and limitations in our current knowledge base.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is, therefore, likely that discontinuation studies employing linear dose reductions,74,83,84,86,87 as recommended in some older guidelines,94 will be more likely to induce withdrawal reactions (including, potentially, withdrawal psychosis) because reductions in D2 antagonism become increasingly large, causing greater likelihood of dopaminergic rebound.”
From A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse (2021) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive Textbook of Psychiatry
Freedman, A. M., & Kaplan, H. I. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196712000-00052 · Cited by 3,825
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,021
Family Interventions for Schizophrenia
Dixon, L. B., & Lehman, A. F. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.631 · Cited by 394
Self-citationPsychopharmacologic Treatment of Schizophrenia
Kane, J. M., & Marder, S. R. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.287 · Cited by 271
Vocational Rehabilitation in Shizophrenia
Lehman, A. F. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.645 · Cited by 239
Self-citationAssertive Community Treatment and Case Management for Schizophrenia
Scott, J. E., & Dixon, L. B. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.657 · Cited by 226
Conventional Antipsychotic Medications for Schizophrenia
Dixon, L. B., Lehman, A. F., & Levine, J. A. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.567 · Cited by 182
Self-citationClozapine: Efficacy and Safety
Buchanan, R. W. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.579 · Cited by 161
Psychological Interventions for Schizophrenia
Scott, J. E., & Dixon, L. B. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.621 · Cited by 134
Risperidone: Efficacy and Safety
Umbricht, D., & Kane, J. M. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.593 · Cited by 73
Adjunctive Treatments in Schizophrenia: Pharmacotherapies and Electroconvulsive Therapy
Johns, C. A., & Thompson, J. W. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.607 · Cited by 57
Ideal and Reality of Neuroleptic Relapse Prevention
Kissling, W. (1992) · The British Journal of Psychiatry · doi:10.1192/s000712500029716x · Cited by 48
Schizophrenia: Treatment of Acute Psychotic Episodes
Levy, S. T., & Ninan, P. T. (1990) · Medical Entomology and Zoology · Cited by 12
Research works printed but not linked: 4
- Kane, J.M. Schizophrenia. New England Journal of Medicine, 334:34-41, 1996.
- Kane, J.M., and Marder, S.R. Psychopharmacologic treat- ment of schizophrenia. Schizophrenia Bulletin, 19(2): 287-302, 1993.
- Lehman, A.F. Vocational rehabilitation in schizophrenia. Schizophrenia Bulletin, 21(4):645-656, 1995.
- Zito, J.M. Psychotherapeutic Drug Manual. 3rd ed. New York, NY: John Wiley & Sons, 1994.
Cited by
Sorted by citations
How stigma interferes with mental health care.
Corrigan, P. (2004) · American Psychologist · doi:10.1037/0003-066x.59.7.614 · Cited by 3,648
Wang, P. S., Lane, M., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.629 · Cited by 2,695
Wang, P. S., Aguilar-Gaxiola, S., Alonso, J., Angermeyer, M. C., Borges, G., Bromet, E. J., Bruffaerts, R., de Girolamo, G., de Graaf, R., Gureje, O., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61414-7 · Cited by 1,655
Undertreatment of people with major depressive disorder in 21 countries
Thornicroft, G., Chatterji, S., Evans-Lacko, S., Gruber, M., Sampson, N., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Andrade, L., Borges, G., et al. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.188078 · Cited by 1,121
Kessler, R. C. (2005) · JAMA · doi:10.1001/jama.293.20.2487 · Cited by 1,101
Metadata
- Authors
- Lehman, A. F., Steinwachs, D. M., & The Co-Investigators of the PORT Project
- Affiliations
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- Corresponding author
- Lehman, A. F.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-01-01
- Volume
- 24
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2121113553
- Cited by
- 910
- References
- 14
- Citations by year
- 2025: 6 · 2024: 5 · 2023: 4 · 2022: 9 · 2021: 11 · 2020: 8 · 2019: 12 · 2018: 23 · 2017: 12 · 2016: 17 · 2015: 14 · 2014: 16 · 2013: 22 · 2012: 41
- FWCI
- 38.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Schizophrenia Bulletin (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia
- MeSH terms
- Combined Modality Therapy, Health Policy, Humans, Research Support as Topic, Schizophrenia, United States, United States Agency for Healthcare Research and Quality, Treatment Outcome, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
